Search research articles
Contact Us
Filters
Showing results (41-50 of 93) with videos related to
Page
of 10
Sort By:
Bioorganic Chemistry
|
December 15, 2021
Discovery of pyrido[3,4-b]indol-1-one derivatives as novel non-covalent Bruton's tyrosine kinase (BTK) inhibitors
Dou Dou, Wenjie Sha, Yanyan Diao, et al.
Bioorganic Chemistry
|
June 6, 2022
Discovery of pyrrolo[1,2-a]quinoxalin-4(5H)-one derivatives as novel non-covalent Bruton's tyrosine kinase (BTK) inhibitors
Rongrong Su, Yanyan Diao, Wenjie Sha, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 21, 2025
Structure-based design of novel pyrrolo[1,2-a]quinoxalin-4(5H)-one derivatives as potent noncovalent Bruton's tyrosine kinase (BTK) inhibitors
Chaoquan Tian, Wenjie Liao, Zhixiao Yu, et al.
Oncotarget
|
August 18, 2016
Discovery of peptide inhibitors targeting human programmed death 1 (PD-1) receptor
Qiao Li, Lina Quan, Jiankun Lyu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
October 28, 2022
Efficacy of WWQ-131, a highly selective JAK2 inhibitor, in mouse models of myeloproliferative neoplasms
Huan Ge, Caolin Wang, Chaoquan Tian, et al.
Journal of Medicinal Chemistry
|
June 29, 2024
Development of Degraders of Cyclin-Dependent Kinases <b>4</b> and <b>6</b> Based on Rational Drug Design
Huan He, Xingsen Zhang, Jie Wang, et al.
Journal of Medicinal Chemistry
|
June 26, 2025
Design, Synthesis, and Biological Evaluation of Macrocyclic 2-Amino-4-phenylaminopyrimidine Derivatives as Potent JAK2 Inhibitors
Wenyi Mei, Xiaotong Jia, Feng Hu, et al.
Journal of Medicinal Chemistry
|
June 3, 2025
Discovery of a Proteolysis-Targeting Chimera Degrader of JAK2 as a Potential Therapeutic Agent for JAK2-Mediated Myeloproliferative Neoplasms
Caolin Wang, Ziqi Chen, Siyu Wang, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 10, 2012
Discovery of novel selective inhibitors for EGFR-T790M/L858R
Fang Bai, Hongyan Liu, Linjiang Tong, et al.
Journal of Chemical Information and Modeling
|
October 15, 2011
Identification of inhibitors against p90 ribosomal S6 kinase 2 (RSK2) through structure-based virtual screening with the inhibitor-constrained refined homology model
Shiliang Li, Yi Zhou, Weiqiang Lu, et al.
Page
of 10
Search research articles
Search
Showing results (41-50 of 93) with videos related to
Sort By:
Page
of 10
Bioorganic Chemistry
|
December 15, 2021
Discovery of pyrido[3,4-b]indol-1-one derivatives as novel non-covalent Bruton's tyrosine kinase (BTK) inhibitors
Dou Dou, Wenjie Sha, Yanyan Diao, et al.
Bioorganic Chemistry
|
June 6, 2022
Discovery of pyrrolo[1,2-a]quinoxalin-4(5H)-one derivatives as novel non-covalent Bruton's tyrosine kinase (BTK) inhibitors
Rongrong Su, Yanyan Diao, Wenjie Sha, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 21, 2025
Structure-based design of novel pyrrolo[1,2-a]quinoxalin-4(5H)-one derivatives as potent noncovalent Bruton's tyrosine kinase (BTK) inhibitors
Chaoquan Tian, Wenjie Liao, Zhixiao Yu, et al.
Oncotarget
|
August 18, 2016
Discovery of peptide inhibitors targeting human programmed death 1 (PD-1) receptor
Qiao Li, Lina Quan, Jiankun Lyu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
October 28, 2022
Efficacy of WWQ-131, a highly selective JAK2 inhibitor, in mouse models of myeloproliferative neoplasms
Huan Ge, Caolin Wang, Chaoquan Tian, et al.
Journal of Medicinal Chemistry
|
June 29, 2024
Development of Degraders of Cyclin-Dependent Kinases <b>4</b> and <b>6</b> Based on Rational Drug Design
Huan He, Xingsen Zhang, Jie Wang, et al.
Journal of Medicinal Chemistry
|
June 26, 2025
Design, Synthesis, and Biological Evaluation of Macrocyclic 2-Amino-4-phenylaminopyrimidine Derivatives as Potent JAK2 Inhibitors
Wenyi Mei, Xiaotong Jia, Feng Hu, et al.
Journal of Medicinal Chemistry
|
June 3, 2025
Discovery of a Proteolysis-Targeting Chimera Degrader of JAK2 as a Potential Therapeutic Agent for JAK2-Mediated Myeloproliferative Neoplasms
Caolin Wang, Ziqi Chen, Siyu Wang, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 10, 2012
Discovery of novel selective inhibitors for EGFR-T790M/L858R
Fang Bai, Hongyan Liu, Linjiang Tong, et al.
Journal of Chemical Information and Modeling
|
October 15, 2011
Identification of inhibitors against p90 ribosomal S6 kinase 2 (RSK2) through structure-based virtual screening with the inhibitor-constrained refined homology model
Shiliang Li, Yi Zhou, Weiqiang Lu, et al.
Page
of 10